NSE: MANKIND
MANKIND PHARMA LIMITED
Price history
-5.27% over 3M
Performance
52-week range
Position in day range
MANKIND stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Sideways
50-DMA ₹2,455.58
RSI (14)
34
Neutral momentum
Volatility (ATR)
2.16%
Moderate
Close streak
5d down
Volume vs 20d avg
0.58x
From 52W high
-16.29%
Up from 52W low
+17.21%
Green days (20)
8/20
Monthly seasonality
Average monthly move for MANKIND across the available price history.
Key statistics
Open
2,260
Day high
2,276.5
Day low
2,235.1
Prev close
2,238.4
Volume
1.81 L
Avg vol (20d)
3.10 L
52W high
2,674
52W low
1,909.7
MANKIND quarterly results
All MANKIND results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹4,031 cr
+12.9% YoY
Net profit
₹568 cr
+29.6% YoY
Operating profit
₹830 cr
+32.2% YoY
EPS
₹13.76
+29.6% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹4,031 cr | ₹830 cr | ₹568 cr | 20.6% | 14.1% | ₹13.76 | +29.6% | +2.5% |
| Q4 FY262026-03-31 | ₹3,443 cr | ₹707 cr | ₹554 cr | 20.5% | 16.1% | ₹13.44 | +31.7% | +35.6% |
| Q3 FY262025-12-31 | ₹3,567 cr | ₹697 cr | ₹409 cr | 19.5% | 11.5% | ₹9.90 | — | -6.7% |
| Q1 FY262025-06-30 | ₹3,570 cr | ₹628 cr | ₹438 cr | 17.6% | 12.3% | ₹10.62 | — | +4.2% |
| Q4 FY252025-03-31 | ₹3,079 cr | ₹452 cr | ₹421 cr | 14.7% | 13.7% | ₹10.20 | — | — |
| TTM (last 4 quarters) | ₹14,611 cr | ₹2,862 cr | ₹1,969 cr | 19.6% | 13.5% | ₹47.72 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.